FLOTEK INDUSTRIES INC quarterly report, Q1 FY2013

Flotek Industries, Inc. — Q1 2013 Form 10-Q

Business context and period: The filing covers the three months ended March 31, 2013. Flotek develops and supplies oilfield chemicals, logistics services, drilling tools, and artificial-lift products. Its reportable segments are Chemicals and Logistics, Drilling Products, and Artificial Lift.

Financial results and liquidity

MetricQ1 2013Q1 2012
Revenue$78.2 million$79.2 million
Gross profit / margin$32.6 million / 41.7%$33.5 million / 42.2%
Operating income$12.5 million$16.7 million
Net income$7.8 million$3.6 million
Diluted EPS$0.15$0.07
Operating cash flow$8.0 million$5.7 million
Capital expenditures$4.4 million$4.1 million

Cash and cash equivalents were $0.2 million at March 31, 2013, down from $2.7 million at year-end 2012. Current assets were $95.4 million and current liabilities were $33.8 million. Total debt, including capital leases, was $27.1 million: $24.4 million on the term loan, $0.8 million on the revolver, and $1.9 million in capital leases. The company had repaid all convertible notes during the quarter. Revolver availability was approximately $49.6 million; the company reported compliance with all debt covenants.

Operating cash flow included $3.7 million of working-capital use, principally higher receivables and lower accounts payable. Investing cash outflow was $3.0 million and financing cash outflow was $7.4 million. The financing activity included $9.2 million of revolver repayments, $6.1 million of debt and lease repayments, and $2.7 million of treasury-stock purchases, partly offset by $10.0 million of revolver borrowings.

Material changes and segment performance

  • Revenue fell 1.2% and gross profit fell 2.5%; operating income declined 25.1%, mainly because of higher SG&A and lower gross profit.
  • Net income increased despite lower operating income, reflecting materially lower interest expense and the absence of prior-year debt-extinguishment and warrant-liability charges. Q1 2012 included a $5.4 million debt-extinguishment loss and a $3.9 million warrant fair-value loss; interest expense also fell from $2.3 million to $0.4 million.
  • Chemicals revenue declined 6.3% to $44.7 million; segment operating income fell 16.3% to $14.3 million. Management cited weaker drilling/completion demand, product-mix pressure, and higher expansion-related costs.
  • Drilling revenue was essentially flat at $28.9 million, with operating income of $5.4 million. Higher product and service revenue offset lower rental revenue.
  • Artificial Lift revenue increased 82.8% to $4.7 million and operating income rose to $1.6 million, supported by international sales and North Dakota expansion.

Outlook, risks, and unusual items

Management’s 2013 operating plan assumes stable industry conditions; the filing provides no specific earnings or revenue guidance. Priorities include international expansion, product development, working-capital management, and selective asset sales. Planned remaining 2013 capital expenditures were $14.9 million, excluding amounts received from lost-in-hole revenue. Chemical capacity expansion and broader Drilling product offerings remained priorities.

Management described continued pricing pressure and volatile market conditions. North American average rig count was down 11.1% year over year, while oil-directed activity and natural-gas prices were higher. Results remain sensitive to commodity prices, drilling and completion activity, customer budgets, and competition. The company also cited customer and supplier concentration risks: one customer represented 17.5% of Q1 revenue, and certain chemical inputs and equipment parts have limited sourcing options. More than 99% of revenue from major customers was in Chemicals.

SG&A included $0.9 million of one-time executive severance expense, $0.8 million for ERP work, $0.9 million for customer-expansion staffing and travel, and $0.5 million of administrative and facility-expansion costs. Management said no pending or threatened litigation was expected to materially affect the company.

Controls issue: Disclosure controls remained ineffective as of March 31, 2013 because previously identified material weaknesses related to ERP implementation and the monthly close process persisted. Management described ongoing remediation efforts.

Investor verification points

  • Track whether Chemicals demand, product mix, and gross margins recover, and whether Artificial Lift growth is sustained.
  • Assess cash conversion and working-capital needs, given low period-end cash and the quarter’s receivables-related cash use.
  • Review borrowing-base availability, debt-covenant compliance, and the effect of continued capital spending on liquidity.
  • Monitor remediation of the ERP and monthly-close material weaknesses and any subsequent changes in control effectiveness.
  • Verify the expected timing and returns of the planned $14.9 million in remaining capital expenditures and the contribution from international expansion.